Coagulation Meds

ACTIVE LEARNING TEMPLATE: Medication STUDENT NAME _____________________________________ MEDICATION __________________________________________________________________________ CATEGORY CLASSHEY ______________________________________________________________________ Jagulant REVIEW MODULE CHAPTER ___________ PURPOSE OF MEDICATION Expected Pharmacological Action MOABlocksconversionofprothrombin thrombin inactivatesthrombin Factor a Therapeutic Use PrescribedFor EvolvingUTROKE pulmonaryEmbolismDVT 3 AfibwtEmboli Complications Medication Administration Caution uncontrolledHTN atulcers RECENTsurgery ROUTE AdverseEffects HITTThrombocytopenia SQ Bev HalfLIFEof40mins Contraindications/Precautions BEEFPorkallergiesthrombocypeniableedingdisorders Pregnancy lactation Safe Interactions Anticoags Antihistamines Digoxin Nitroglycerin Nicotine Nursing Interventions seconds TherapeuticEffects PTT4580 i si STOP if platelet ii i 1001000 Client Education PREVENTS CLOTS doesnotdissolve Evaluation of Medication Effectiveness apttlevelsof60tosoreconds thrombi developmentofvenous Nodevelopment Nofurther ACTIVE LEARNING TEMPLATES ACTIVE LEARNING TEMPLATE: Medication STUDENT NAME _____________________________________ EN ftp.giiyhfENOX low MEDICATION __________________________________________________________________________ Molecular weightHeparin REVIEW MODULE CHAPTER ___________ CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action MOA InactivatesFactorXa Therapeutic Use preventsfurtherdevelopmentofclots TreatDVT PE Complications Medication Administration AdverseEffects ThrombocytopeniaToxicity NeurologicalDamage Route SQ weightbased Onset 3 5hrs than HalfLife 2 to4timeslonger µ flairbubble Contraindications/Precautions Pregnancy lactation riskvsreward CautionSpinalBlockEpidural Nursing Interventions MonitorvitalVigns plateletcount Antidote ProtamineSulfate Interactions AntiplateletagentsOTCNSAIDsAspirin Labs CBC checkplateletCOUNT STOP if platelet 1001000 Client Education Evaluation of Medication Effectiveness No development Nofurtherdevelopmentofvenousthrombi ACTIVE LEARNING TEMPLATES USESOFTtoothbrush III BE L gpetechia HR BP ACTIVE LEARNING TEMPLATE: Medication STUDENT NAME _____________________________________ MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ warificiagulant CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action MOA exhibitsvitamin k Therapeutic Use I fforYETftpMiitmorihan TIA latneartvaives risk recurrent Complications Medication Administration BleedingHepatitisToxicity II fi surgery Discontinue 7daysbefore TherapeuticEffects Contraindications/Precautions If 30seconds BlooddisorderHepaticdisease atulcersETOHuse Eh fatient Nursing Interventions lowproteinlevels Antidote Vitamink MonitorvitalvignsPT liverENZYMES CBC INR Interactions BactrimNSAIDsPPIsBirthControlSpironolactone Foodshighin vitamin K mustconsumesameamountconsistantly VanpalmettocoenzymeQ 10garlicgingerFeverfewglucosamine gingkobalboa Evaluation of Medication Effectiveness Labvaluemonitoring 1 IE Hi5mescontrol thrombi Nofurtherdevelopmentofvenous ACTIVE LEARNING TEMPLATES Client Education IE's.IE sinYrusn if Is BEEtgpetechia HRIBP ACTIVE LEARNING TEMPLATE: Medication STUDENT NAME _____________________________________ Clop MEDICATION __________________________________________________________________________ platelet CATEGORY CLASS ______________________________________________________________________ REVIEW MODULE CHAPTER ___________ PURPOSE OF MEDICATION Expected Pharmacological Action MOA Therapeutic Use plateletaggregationstopsthemfromdumping If ftp.ai i schemic stroke Complications angina Medication Administration AE GlupsetabdominalpainNAUSEAdiarrhea Bleeding Thrombocytopenia Route PO loadingdoesmaybeneeded surgery Discontinue 7daysbefore Contraindications/Precautions Caution Children If HEY ONPepticUlcerDisease PUD Lactation Nursing Interventions if Pregnancy riskvsreward ftpfffffffnsa Interactions as ASA StatinsNSAIDsSSRIOmeprazole Client Education Reportanyunusualbleeding Evaluation of Medication Effectiveness HEN fffE.fi NO OTCNSAIDS fhhfmsbosis tissue p erfusion blood adequate flow ACTIVE LEARNING TEMPLATES nounusualbleeding aspirinuse Notifyproviderregarding ACTIVE LEARNING TEMPLATE: Medication STUDENT NAME _____________________________________ MEDICATION __________________________________________________________________________ ASPLEY REVIEW MODULE CHAPTER ___________ platelet CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Therapeutic Use MOA b Plateletaggregationstopsthemfromdumping M prevention Complications Medication Administration AE Glupset NAUSEAdyspepsiavomiting Hemorrhagicstroke a Bleed Thrombocytopenia HearingLossTinnitus Route po surgery Discontinue 7daysbefore minutes ONSET 5 30 Contraindications/Precautions ua.at iiiiii Nursing Interventions FORHearingloss L.tt Interactions Y.Y.n.si fi balboa EEi.fEaEY.ggucosaminagingko Client Education Evaluation of Medication Effectiveness ofarterialthrombosis adequatetissueperfusion bloodflownounusualbleeding Absence ACTIVE LEARNING TEMPLATES Reportanyunusualbleeding Ñffypirofidderregardingaspirinuse ACTIVE LEARNING TEMPLATE: Medication STUDENT NAME _____________________________________ MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ CATEGORY CLASSYishnytic ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action MOA dissolvesclotsthathavealreadyformed Therapeutic Use M1 PE ischemicstrokesCVLPatency Complications AE Medication Administration Bleeding Route evonly cannotgivewhoCTSCAN m IIIT.IEfor 34.5hrs Contraindications/Precautions 429 ischemicCVA caproic Antidote Amino Acid lesionsactiveinternal bleed cranialHemorrhagecerebral L Nursing Interventions Monitorchanges in vitalsLOCWeakness Neurostatus Interactions Alps HeparinWarfarinThrombolyticAntiplatelet labsaptt.PTHgb Hct Client Education Reportunusualbleeding Evaluation of Medication Effectiveness EvidenceofThrombuslysis restorationofcirculation ACTIVE LEARNING TEMPLATES ACTIVE LEARNING TEMPLATE: Medication STUDENT NAME _____________________________________ MEDICATION __________________________________________________________________________ nDextrancers i ffd FEFY.im ifsat CATEGORY CLASS ______________________________________________________________________ REVIEW MODULE CHAPTER ___________ PURPOSE OF MEDICATION Expected Pharmacological Action needed Provigesce you Therapeutic Use forRBCDevelopment302transport usedtotreatpreventirondeficiencyanemia Complications Medication Administration IIIhat hffa 9s s kingeminjections AnaphylaxisHypotensiongreen tarrystools RouteFerroussulfatePo IronDextran ev Contraindications/Precautions 01 PUD severeliverdisease Nursing Interventions Monitorvitalsignsbowelpatterns observeforAnaphylaxis toxicity Interactions Antacids ABXsDextran ACEinhibitors Client Education Takeonemptystomach ifpossible Evaluation of Medication Effectiveness III Fatigue it In pallorshouldsubside ACTIVE LEARNING TEMPLATES 5 S ua take avitamincto aster.arinkwutran enhanceabsorption Avoidcaffine diary ACTIVE LEARNING TEMPLATE: Medication STUDENT NAME _____________________________________ MEDICATION __________________________________________________________________________ Vitti.im CATEGORY CLASS ______________________________________________________________________ is'iiiiiiiai REVIEW MODULE CHAPTER ___________ PURPOSE OF MEDICATION Expected Pharmacological Action Converts FolicAcidintoactiveform Therapeutic Use Tx vitaminB12deficiency Complications Hypokalemia muscleweaknessirregularHR MegaloblasticAnemia Medication Administration food latter not Route Nasalgivethebefore Parental Oncemonthly Glupsetnauseavomitingdiarrheadyspepsia Contraindications/Precautions C1 pregnancy lactation Nursing Interventions ofvitaminB12deficiency theFfg9ns pH Interactions B12deficiency can bemasked if takingFolicAcid Client Education Takew food Evaluation of Medication Effectiveness reticulocytecount hematocrit ACTIVE LEARNING TEMPLATES ACTIVE LEARNING TEMPLATE: Medication STUDENT NAME _____________________________________ MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ Titimits minerals CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Essential in ProductionofDNA Erythropoiesis Complications Bronchospasm Therapeutic Use am anemiasecondarytoFolic f Yffjic Medication Administration Route PO Contraindications/Precautions Nursing Interventions ASSESSFOR signs ofmegaloblastic anemia acidHghHct Obtain baselinefolic Interactions RBC Anticonvulsants Client Education Evaluation of Medication Effectiveness Folatelevel wlinNormalRange countHghHcttonormalrange ReturnofRBCreticulocyte tubedefectinNewborns Absenceofneural ACTIVE LEARNING TEMPLATES NoETOH intakeoffoodswtfolicacid ACTIVE LEARNING TEMPLATE: Medication STUDENT NAME _____________________________________ MEDICATION __________________________________________________________________________ EPÉÉjth iesis StimulatingAgent REVIEW MODULE CHAPTER ___________ CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Therapeutic Use Tx AnemiainPtsw CKDAnemiasecondaryto chemotherapy ZidovudinefromHIVAIDSmeds Stimulateproduction of RBC Complications III I III II Medication Administration aches risk for route sa or ev Contraindications/Precautions Cl Lactationalbuminallergy Riskvsreward Caution Normalrenalfunction Pregnancy Interactions Nursing Interventions MonitorBP Client Education Evaluation of Medication Effectiveness Hbglevelof10to11gal maxnotof33 ACTIVE LEARNING TEMPLATES Ef s